Elke De Bruyne Selected Research

ABR-238901

10/2017

Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elke De Bruyne Research Topics

Disease

30	Multiple Myeloma 02/2022 - 09/2004
25	Neoplasms (Cancer) 02/2022 - 09/2004
5	Neoplasm Metastasis (Metastasis) 11/2021 - 09/2004
2	Hypoxia (Hypoxemia) 02/2022 - 09/2013
2	Disease Progression 11/2021 - 05/2008
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2019 - 01/2019
2	Lymphoma (Lymphomas) 11/2019 - 01/2019
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2019 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 11/2019 - 01/2013
2	Inflammation (Inflammations) 10/2017 - 12/2015
1	Bone Diseases (Bone Disease) 11/2018
1	Osteolysis 01/2016
1	Monoclonal Gammopathy of Undetermined Significance 01/2016
1	Enuresis 12/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2010

Drug/Important Bio-Agent (IBA)

9	Bortezomib (Velcade)FDA Link 02/2022 - 11/2012
5	MethyltransferasesIBA 01/2021 - 04/2013
5	Histone Deacetylase InhibitorsIBA 01/2018 - 04/2013
5	CytokinesIBA 10/2017 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 04/2013
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2012
3	Pharmaceutical PreparationsIBA 11/2019 - 01/2018
3	Insulin-Like PeptidesIBA 01/2016 - 04/2012
2	Phosphotransferases (Kinase)IBA 01/2020 - 11/2019
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 11/2019 - 11/2018
2	venetoclaxIBA 11/2019 - 01/2019
2	Anaphase-Promoting Complex-CyclosomeIBA 01/2019 - 01/2016
2	Proteasome InhibitorsIBA 02/2016 - 09/2013
2	LigandsIBA 01/2016 - 01/2016
2	Insulin-Like Growth Factor Binding ProteinsIBA 01/2016 - 01/2016
2	Galactosylceramides (Galactocerebrosides)IBA 12/2014 - 01/2013
1	Oxidoreductases (Dehydrogenase)IBA 02/2022
1	Pargyline (Pargyline Hydrochloride)FDA Link 02/2022
1	Proline (L-Proline)FDA Link 02/2022
1	delta-1-pyrroline-5-carboxylateIBA 02/2022
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2022
1	BIX 01294IBA 11/2021
1	Histone MethyltransferasesIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	1- (6- (3,5- dichloro- 4- hydroxyphenyl)- 4- ((4- ((dimethylamino)methyl)cyclohexyl)amino)- 1,5- naphthyridin- 3- yl)ethanoneIBA 11/2019
1	CaspasesIBA 11/2019
1	Axl Receptor Tyrosine KinaseIBA 11/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	GW 4869IBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 04/2018
1	EnzymesIBA 01/2018
1	ChromatinIBA 01/2018
1	trametinibIBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	Cell Cycle ProteinsIBA 10/2017
1	S100 Proteins (S 100 Protein)IBA 10/2017
1	Calgranulin BIBA 10/2017
1	ABR-238901IBA 10/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2016
1	UbiquitinIBA 02/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 04/2015
1	AntibodiesIBA 04/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2014
1	ChemokinesIBA 06/2014
1	Decitabine FDA Link 05/2014
1	TH 302IBA 09/2013
1	ProdrugsIBA 09/2013
1	Drug CombinationsIBA 04/2013
1	Immunologic Factors (Immunomodulators)IBA 01/2013
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 11/2012
1	picropodophyllinIBA 04/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2012
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2010
1	Insulin (Novolin)FDA Link 03/2010
1	forodesineIBA 01/2010
1	ThymosinIBA 01/2010
1	Purine-Nucleoside PhosphorylaseIBA 01/2010
1	Peptides (Polypeptides)IBA 01/2010
1	thymosin beta(4)IBA 01/2010
1	deoxyguanosine triphosphate (dGTP)IBA 01/2010
1	TetraspaninsIBA 05/2008
1	Matrix Metalloproteinases (MMPs)IBA 09/2004

Therapy/Procedure

4	Therapeutics 02/2022 - 01/2011
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 11/2019
1	Immunomodulation 02/2015